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Abstract: Patients with severe chronic obstructive pulmonary disease (COPD) are unable to exercise 
at high intensities for sufficiently long periods of time to obtain true physiological training effects. It 
therefore appears sensible to increase training duration at sub-maximal exercise intensities to 
optimize the benefit of exercise training. We compared the effects on exercise tolerance of two 
endurance cycloergometer submaximal exercise protocols with different cumulative training loads 
(one (G1) versus two (G2) daily 40 min training sessions) both implemented over 20 consecutive days 
in 149 patients with COPD (forced expiratory volume at first second (FEV1): 39% predicted) admitted 
to an inpatient pulmonary rehabilitation program. Patients in G2 exhibited greater improvement (p = 
0.011) in submaximal endurance time (from 258 (197) to 741 (662) sec) compared to G1 (from 303 (237) 
to 530 (555) sec). Clinically meaningful improvements in health-related quality of life, 6MWT, and 
chronic dyspnea were not different between groups. Doubling the volume of endurance training is 
feasible and can lead to an additional benefit on exercise tolerance. Future studies may investigate the 
applicability and benefits of this training strategy in the outpatient or community-based pulmonary 
rehabilitation settings to amplify the benefits of exercise interventions.  
Keywords: COPD; exercise training; pulmonary rehabilitation 
 
1. Introduction  
Exercise training is the cornerstone of pulmonary rehabilitation, with endurance training 
representing the most commonly implemented modality in this setting for patients with chronic 
obstructive pulmonary disease (COPD). The benefits of endurance training in this population are well 
documented and include reductions in hospitalization and exacerbation rates, sensations of 
breathlessness during daily activities, and improvements in exercise tolerance, functional capacity, and 
health-related quality of life [1]. 
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In outpatients with COPD, recommended training programs consist of a minimum of 16–20 
sessions, each lasting for 30–90 minutes, that are performed 3–5 times per week, at an intensity 
equivalent to 60–80% of peak exercise capacity (Wpeak) [2]. In inpatients with COPD, training 
frequency may increase to 5 times per week with similar loading characteristics as for outpatients with 
COPD [3]. 
In healthy young individuals there is strong evidence that the higher the endurance training 
volume, the greater the magnitude of physiological adaptations [4]. In older healthy people, there is, 
however, a less clear dose–response effect for endurance exercise training volume [5,6]. 
In patients with COPD, there are studies comparing the physiological benefits of different 
endurance training intensities [7–9], within or across different exercise training modalities (continuous 
vs. interval training) [10–12]. The optimal training intensity that is tolerable by the majority of patients 
and that yields the greatest physiological benefits is still unclear [13]. 
Exercise training volume refers to the product of intensity applied over a given duration during a 
bout of exercise and is used to calculate the training dose of exercise. Training volume may be 
increased by increasing the exercise duration, the exercise intensity, or both [14]. However, severe 
COPD patients are unable to exercise at high intensities for sufficiently long periods of time to obtain 
true physiological training effects due to central cardiopulmonary and peripheral muscular limitations 
[15,16]. It therefore seems sensible to increase training duration at a given sub-maximal intensity in 
these patients to optimize the benefit of exercise training. This approach is feasible and may elicit 
greater physiological benefits compared to the standard training programs outlined in the joint 
American Thoracic Society/European Respiratory Society (ATS/ERS) statement on pulmonary 
rehabilitation [2]. 
Accordingly, the aim of this pragmatic randomized controlled trial was to compare the effects on 
exercise tolerance of two endurance cycloergometer exercise protocols with different cumulative 
training loads (one versus two daily 40 min training sessions) implemented over 20 consecutive days in 
severe COPD patients admitted to an inpatient pulmonary rehabilitation program. We also assessed 
the effects of the two programmes on respiratory and peripheral muscle strength, symptoms, 
health-related quality of life, and the acceptability and adherence to the different training programmes 
(patients’ satisfaction, dropouts, and side effects) and explored potential associations between the 
baseline patient characteristics and the magnitude of improvement in exercise tolerance following 
exercise training. We hypothesized that two daily training sessions would be superior to a single daily 
session in terms of improving exercise tolerance.  
2. Experimental Section 
2.1. Study Population 
Eligible participants were consecutive stable inpatients with severe COPD, diagnosed according 
to the Global Initiative for Lung Diseases criteria [17] and referred by their physicians to pulmonary 
rehabilitation. Inclusion criteria were as follows: forced expiratory volume at first second/forced vital 
capacity (FEV1/FVC) <70% and FEV1 <50% of predicted values and clinical stability (no changes in 
medication within the previous 10 days). Exclusion criteria were as follows: 1) participation to a 
program of pulmonary rehabilitation including exercise training within the previous six months, 2) the 
necessity of modification of drug therapy within the previous 15 days, 3) a recent acute myocardial 
infarction within the previous three months, 4) a presence of chronic heart failure, 5) severe 
musculoskeletal conditions limiting the ability to perform regular exercise, 6) previously reported 
psychiatric conditions, and (7) cognitive impairments (mini-mental state examination <22) [18]. When 
exacerbations requiring a strong modification of drug therapy (a need for antibiotic and/or oral steroid) 
occurred during the course of the study, patients discontinued their participation to the study. Data 
from patients exhibiting a low compliance with the programme (i.e., missing more than five 
consecutive days of training sessions since the onset of the program) were excluded from the analysis. 
All institutes provided ethics approval for the trial (protocol number 1066 Ethics Committee, session of 
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11 May 2015), and all participating patients gave their written informed consent. The trial was 
registered on the clinicaltrials.gov website (NCT02522637). 
2.2. Study Design 
This was a prospective, multicenter, two parallel groups (one versus twice daily training), 
randomized controlled trial. The study was carried out at the Pulmonary Rehabilitation Department of 
the Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy. The centers that were involved in the study 
were as follows: Lumezzane (BS), Pavia, Cassano delle Murge (BA), Telese Terme (BN), Tradate (VA), 
and Veruno (NO). All patients included in the study undertook a comprehensive pulmonary 
rehabilitation program that was delivered by experienced multidisciplinary teams consisting of 
physicians, physiotherapists, nurses, physiologists, and other health care professionals. The 
physiotherapist who conducted the initial and final assessments was blinded on the patient’s 
allocation. Patient blinding was not possible due to the nature of the study, and the physiotherapist 
who supervised the training was not blinded. Following baseline assessment, patients were 
randomized according to a computerized randomization list (www.randomization.com) with a block 
design and an allocation ratio of 1:1. A data manager, who kept and consulted the randomization list, 
communicated patients’ allocation to the physiotherapists responsible of the study in each center that 
was blinded to the randomization. Randomization was stratified by FEV1 (<50% predicted or >50% 
predicted). 
2.3. Assessments 
At enrolment, baseline anthropometrical and clinical data were collected. Comorbidities were 
assessed by the Cumulative Illness Rating Scale (CIRS) scale [19]. At baseline and at the end of the 
training program, all patients underwent the following assessments: 
• The Six-Minute Walking Test (6MWT), performed according to ATS/ERS [20]. 
Supplemental oxygen, when needed (SpO2 < 90%), was delivered at the flow prescribed by 
the physician and was kept at the same level during both assessment time points. 
Predictive values were calculated according to Chetta et al. [21]. We evaluated meters 
walked and percentage of patients that improved above the minimal clinical important 
difference (MCID) of 30 m [20]. 
• The Constant Work Rate Exercise Test (CWR) (primary outcome) [22], cycling with a load 
set at 70% of the individual maximum predicted load, calculated according to the 
equation of Luxton et al. [23]. Patients pedaled at 50–60 revolutions per minute at constant 
load until their limit of tolerance (reaching Borg dyspnea or fatigue ≥8, or a ≥90% 
maximum theoretical heart rate). Endurance time to the limit of tolerance (in seconds) was 
measured, and pre-to-post variation (before and after the training program) was 
calculated. We also defined the percentage of patients with an improvement above the 
minimal clinical important difference (MCID) of 105 s [22]. 
• Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), collected at 
the mouth in the seated position were performed according to the ATS/ERS indications 
[24]. Predicted values were calculated according to Black and Hyatt [25]. 
• Maximal voluntary contraction (MVC) of the quadriceps muscles was carried out using a 
hand-held dynamometer (Chatillon DMG-200, Ametek, Largo, FL, USA). Body positions 
for the tests were standardized, and predictive values were calculated using the method 
proposed by Andrews et al. [26]. 
• Medical Research Council (MRC) dyspnea, on a 0–5 scale, with 0 corresponding to no 
dyspnea and 5 to the worse level of dyspnea [27]. 
• Health-related quality of life by the COPD Assessment Test (CAT), on a 0-40 scale, with 40 
corresponding to the greatest impact of COPD on quality of life [28], by the Maugeri 
Respiratory Failure modified scale (MRF-26) [29]. 
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In addition, at the end of the program, patients’ perceived satisfaction with regard to “quality of 
training perception” was investigated using a 0–4 Likert scale [30], with the following answers:  
0 = very bad; 1 = bad; 2 = sufficient; 3 = good; 4 = very good. 
Perception of “quantity of training” was tested by the following question: “How do you define the 
amount of the training performed?” with three possible answers: 0 = not sufficient; 1 = good; 2 = too 
much. Side effects during training and drop-out rates were monitored.  
2.4. Interventions 
Patients performed a comprehensive inpatient pulmonary rehabilitation program lasting for 20 
consecutive days including exercise training, psychological support, medical assessment, educational 
components of COPD management, and chest physiotherapy when necessary. The exercise program 
included endurance training and active mobilization exercises as follows. 
2.4.1. Endurance Training 
Patients enrolled were randomized into two groups and undertook one of the following exercise 
interventions: 
• Group 1 (G1) underwent a single daily 40-minute session carried out in the morning or in 
the afternoon according to individual preferences for 20 consecutive days (20 sessions in 
total).  
• Group 2 (G2) underwent two daily 40-minute sessions for 20 consecutive days (40 
sessions in total) comprising one session in the morning and one session in the afternoon; 
sessions were separated by at least three hours of rest in between. 
Each session of training consisted of 40 minutes of cycling at moderate-high intensity (30 minutes 
of cycling at a constant load, a 5-minute warm-up, and a 5-minute cool-down without load). Starting 
load intensity was set at 50% of the maximum predicted load in watts according to the equation of 
Luxton et al. [23] based on gender, age, and distance walked during the 6MWT aiming for dyspnea 
and/or leg discomfort scores equivalent to 4–5 on the Borg scale. Management of intensity progression 
in subsequent sessions was carried out based on symptoms of dyspnea and fatigue on the Borg scale 
[31] previously described by Maltais et al. [16]. Briefly, we increased the load by 10 watts per session 
when in the preceding session patients defined their dyspnea and/or leg discomfort as less than 4–5 on 
the Borg scale; the workload was decreased if dyspnea or leg discomfort scores were greater than 4–5 
or the heart rate exceeded 90% of the predicted maximal heart rate (220 minus age). 
Oxygen pulsoximetry (SpO2), blood pressure, perceived dyspnea and leg discomfort on the Borg 
scale were measured at the beginning and at the end of each training session; heart rate was 
continuously monitored by telemetry. 
2.4.2. Active Mobilization Exercises 
Following each 40 min cycling session, all patients underwent a 20-minute session including the 
following exercises supervised by a physiotherapist: cool-down and group active mobilization, 
mild-intensity strengthening, and free-body exercises using lightweight, sticks, and balls.  
Medication was optimized before starting the training program and any changes were recorded 
during the study period. During exercise, the use of oxygen therapy was allowed in case of patients 
showing SpO2 values <90%, and it was delivered at a flow sufficient to maintain an SpO2 value >90%. 
2.5. Statistics 
To detect the sample size, the hypothesis was that the primary endpoint (the endurance time 
during constant work rate exercise testing: CWR) improved by a minimum of 120 s more in G2 as 
compared to G1 [9]. Considering a 1:1 randomization ratio, a study power of 90% where p < 0.05 and 
hypothesizing a standard deviation of a primary endpoint of 200 s, a minimum total sample size of 118 
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patients was calculated. Because of the severity of the population, we took into account a 25% dropout 
rate and increased our total sample size by 30, estimating a total sample size of 148 patients. 
Statistical analysis was conducted by statistical software STATA 13 (StataCorp, LP, College 
Station, TX, USA). 
Descriptive statistics of all measured variables were performed indicating mean and standard 
deviation for continuous variables and frequency distributions for categorical and ordinal variables. 
Analytical statistics tested the pre-to-post difference of response in the two groups by t-tests. We 
compared the different rate of patients who improved the 6MWT and the CWR by Pearson Chi2 test  
and evaluated the risk of improvement by odd ratio analysis using the Improvers/Not Improvers 
groups (see above, in the Assessments section) as variables dependent and baseline characteristics 
(FEV1%, FVC%, Residual Volume (RV)%, FEV1/FVC%, age, sex, body mass index (BMI), chronic 
respiratory failure (CRF), partial pressure of arterial oxygen/inspiratory fraction of oxygen 
(PaO2/FiO2), partial pressure of arterial carbon dioxide (PaCO2), 6MWT, CWR) and group allocation 
as independent variables. Trends of workload, heart rate, and symptoms during training were 
analyzed by mixed effect analysis of variance (ANOVA) with time and group as factors. All statistical 
tests were considered significant when P < 0.05.  
3. Results 
3.1. Study Population 
From June 2015 to May 2018, 950 COPD patients were evaluated to our pulmonary rehabilitation 
(PR) program. Seven hundred ninety-one did not fulfill the inclusion criteria and were excluded, 10 
refused to participate, and 149 were enrolled. Seventy-eight (78) were allocated to Group 1 and 71 to 
Group 2. During the time course of the study, a total of 31 (20.8%) patients discontinued the 
programme, while 118 patients completed the study. Reasons for discontinuing the programme were 
as follows: refused to continue (3), transferred to another hospital (6), hemoptysis (1), respiratory 
exacerbation (5), severe arrhythmias (7), severe muscle soreness (5), no compliance (3), and heart attack 
(1). The trial profile of the study (CONSORT diagram) is illustrated in Figure 1. 
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Figure 1. CONSORT Trial flow of the study. 
Table 1 describes the anthropometric and clinical characteristics of the patients studied. 
Table 1. Anthropometric and clinical characteristics of included patients. 
MEASURES 
Group 1 
(n = 78) 
Group 2 
(n = 71) P 
Sex, male/female 60/18 53/18  0.8200 
Age, years 69 (9) 69 (8) 0.9818 
BMI, Kg/m2 25.53 (5.46) 25.61 (4.09) 0.9118 
FEV1, %predicted 39.54 (11.93) 39.56 (11.36) 0.9303 
FVC, % 75.03 (19.73) 75.32 (17.26) 0.9428 
FEV1/FVC 43.94 (11.41) 42.75 (10.20) 0.4930 
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RV, % 180 (56) 180 (53) 0.7619 
MIP, cmH2O 66.59 (22.28) 69.43 (25.22) 0.2517 
MEP, cmH2O 90.33 (35.77) 85.73 (32.88) 0.4822 
LTOT, % 60 59 0.7940 
CIRS, 1st item, score 2.27 (2.92) 2.09 (3.16) 0.6939 
CIRS, 2nd item, score  2.51 (1.42) 2.49 (1.61) 0.8131 
PaO2/FiO2 310 (53) 308 (45) 0.5410 
PaCO2, mmHg 40.47 (6.31) 40.54 (5.63) 0.7083 
pH 7.42 (0.03) 7.43 (0.03) 0.0951 
6MWT, meters 376 (92) 358 (88) 0.4202 
CWR, s 288 (226) 246 (186) 0.2592 
MRC, score 3.31 (4.13) 2.57 (1.07) 0.1630 
MVC, quadriceps, Kg 24 (7) 24 (9) 0.9415 
MRF26, score 11.53 (6.811) 9.98 (5.97) 0.2058 
CAT, score 21 (7.25) 20.33 (6.76) 0.7762 
Legend: % = percentage, FEV1 = forced expiratory volume 1, FCV = forced vital capacity, RV = residual 
volume, MIP = maximal inspiratory pressure, MEP = maximal inspiratory pressure, LTOT = long-term 
oxygen therapy, CIRS = Cumulative Illness Rating Scale, PaO2 = arterial pressure of oxygen, FiO2 = 
inspiratory fraction of oxygen, PaCO2 = arterial pressure of carbon dioxide, 6MWT = Six-Minute 
Walking Test; CWR = Constant Work Rate Exercise Test, MRC = Medical Research Council Dyspnea 
score, MRF26 = Maugeri Respiratory Failure-26 Scale, CAT = COPD Assessment Test. 
Patients enrolled exhibited severe obstruction, with a high degree of lung hyperinflation. They 
had a moderate dyspnea during daily living and more than half of them were on long-term oxygen 
therapy. Exercise tolerance and quality of life were profoundly compromised (Table 1). 
3.2. Intervention Results 
Figure 2 presents a box plot of changes in the primary outcome (Time to Limitation (Tlim) for 
CWR), while Table 2 describes pre-to-post changes in secondary outcomes of the study and the 
differences between groups (mean difference (95% Confidence Interval) = 252 (54–451)). 
 
Figure 2. Pre-to-post changes in endurance time of CWR (primary outcome). 
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Table 2. Pre-to-post changes in secondary outcomes. 
 Group 1  
(n = 61) 
Group 2  
(n = 57) 
  
 Baseline At the end P 
Pre-to-post 
Baseline At the end P 
Pre-to-post 
Differences  
between groups  
(G2-G1) 
Mean (IC 95%) 
P 
between groups 
6MWT, meters 373 (89) 416 (89) 0.001 360 (93) 410 (99) 0.001 7.953 (−14.44, 30.35) 0.4832 
MIP, cmH2O 67 (23) 74 (23) 0.0471 72 (26) 76 (20) 0.2538 −3.05 (−11.8, 5.7) 0.4900 
MEP, cmH2O 92 (39) 104 (47) 0.040 86 (33) 99 (34) 0.0002 0.939 (−12.36, 14.23) 0.8887 
Quadriceps, Kg 24.4 (7.2) 25.1 (7.5) 0.5164 25 (9.2) 27 (10.9) 0.2690 1.29(−2.90, 5.48) 0.5400 
MRC, score 3.6 (4.9) 1.7 (1.2) 0.007 2.7 (1.1) 1.5 (1) 0.0001 0.763(−0.07, 2.20) 0.2960 
CAT, score 21.5 (7.6) 14.4 (7.8) 0.001 21.1 (7.1) 11.9 (7) 0.0001 −2.03(−5.08,1.02) 0.1900 
MRF, score 11.53 (6.8) 8.22 (6.7) 0.001 9.98 (5.97) 7.28 (5.81) 0.0001 0.6122 (−1.20, 2.43) 0.5049 
Legend: 6MWT = Six-Minute Walking Test; MIP = maximal inspiratory pressure; MEP = maximal inspiratory pressure; MRC = Medical Research Council Dyspnea score; CAT 
= COPD Assessment Test; MRF26 = Maugeri Respiratory Failure-26 Scale; IC 95% = 95% confidence interval (lower value, upper value).
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The primary outcome (cycloergometer endurance time) improved more in G2 (by 483 sec) (from 
258 (197) to 741 (662) sec) than in G1 (by 227 sec) (from 303 (237) to 530 (555) sec); (p = 0.0113), 
whereas all the other outcome measures showed no significant differences in the magnitude of 
improvement between the two groups. Interestingly, the percentage of improvers in cycloergometer 
endurance time in G2 was greater than that in G1 (Figure 3). Quadriceps muscle strength was not 
improved in neither of the groups, and MIP did not improve in G2. 
The allocation to G2 doubled the prospect of improvement in exercise tolerance (seconds) 
during CWR (OR 2.43; 95% IC 1.073–5.513, p = 0.031) and in walking distance (meters) during the 
6MWT (OR 2.50; 95% IC 1.165-5.362, p = 0.019) compared with the allocation to G1. No other baseline 
variables affected the improvement in cycling endurance time, while improvement in the 6MWT 
was related to CRF presence (OR 0.4193, IC 95% 0.1949–0.9038, p = 0.027) and the 6MWT baseline 
(OR 0.9930, IC 95% 0.9885-0.9975, p = 0.002), the hypoxemic and the more disabled patients being 
more likely to improve.  
Figure 3 shows that, when compared to G1, G2 included more patients who improved above 
MCID during both the cycling test (p = 0.043) and the 6MWT (p = 0.045).  
 
Figure 3. Fraction of improvers above MCID CWR (105 s) [22] and in 6MWT (30 m) [20] tests. 
Patients’ satisfaction was similar between groups with regard to quality perception of the 
rehabilitation program (G1: 2 = 13.79%; 3 = 55.17%, 4 = 31.03% versus G2: 2 = 10.91%; 3 = 45.45%,  
4 = 43.62%. p = 0.382) and the amount of training load (G1: 0 = 6.56%; 1 = 85.25%, 2 = 8.2% versus G2:  
0 = 3.51%, 1 = 84.21%, 2 = 12.28% p = 0.0599).  
3.3. Training Program Progression 
The initial training intensity on the cycloergometer was 26.33 (10.55) watts in G1 and 26.41 
(12.37) watts in G2 (p = 0.097), whereas the magnitude of improvement in cycling total training 
workload from the initial training session was greater in G2 (increase by 114 (121)%) compared to G1 
(increase by 83 (82)%); (p = 0.0179)). The day-by-day trend of modification of workload, heart rate, 
and lower recorded symptom scores for dyspnea and leg discomfort is presented in Figure 4.  
J. Clin. Med. 2019, 8, 1052 10 of 14 
 
 
Figure 4. A: Day by day workload (expressed percentage improvement from the initial training 
session), B: heart rate and C/D symptoms during training. Closed circles = twice daily (G2); open 
squares = once daily (G1). The values for G2 are the average of maximum values over the two daily 
training sessions. Error bars indicate standard error (SE) of the mean. P refers to the ANOVA time 
group factor. 
4. Discussion 
The major finding of the study is that in patients with severe COPD doubling the volume of 
endurance training (twice daily as opposed to once daily) has led to an additional benefit on cycling 
exercise tolerance following the completion of an inpatient pulmonary rehabilitation programme. 
Other clinical and functional outcome measures significantly and meaningfully improved, with the 
fraction of patients exhibiting clinically meaningful improvements in both exercise capacity 
measures (cycloergometer endurance time and the 6MWT), which were significantly greater for 
those patients trained twice daily. Furthermore, patients assigned to the twice-daily exercise training 
group well adhered to the increased physical training demands of the programme and afforded a 
100% increase in overall training workload. Therefore, our findings suggest that in inpatients with 
severe COPD, increasing the daily volume of moderate-intensity exercise training is well tolerated 
and yields additional benefits on exercise capacity. This finding is of clinical significance when 
considering pulmonary rehabilitation in the inpatient setting.  
Traditional approaches and guidelines of exercise prescription in patients with COPD 
recommend a target training load above 60% of peak exercise capacity, with progressive increases 
over time and a frequency ranging from 3 to 5 sessions per week, with a minimum of 20 sessions 
[13,32]. However, as it has been known for quite some time, few patients with severe COPD can 
tolerate training intensities at 60–80% peak capacity for 30 consecutive minutes; typically these 
severe COPD patients are capable of progressively sustaining exercise intensities with a peak 
capacity between 50 and 60% [16]. Our approach to provide patients with such tolerable exercise 
intensities for prolonged periods of time on a daily basis over a course of 20 days has proven both 
feasible and effective even for those patients who were required to exercise at moderate intensities 
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twice daily. Furthermore, our approach is in line with approaches of training prescription which 
have been successfully applied in healthy sedentary and trained individuals [33]. 
Our study is the first of its kind in testing the possibility to regularly exercise COPD patients 
with a high training volume (ten 30-minute sessions a week), while improving important patient 
outcomes. In line with our results, recently Morris et al. suggested that the impact of training volume 
can influence the physiological improvement more that the intensity applied, suggesting a need for 
further investigation into the “dose” of endurance training [13]. Our findings thus provide a novel 
element regarding the tailoring of training prescription, beyond the current training 
recommendations [2]. 
The present study shows that both groups exhibited a clinically meaningful improvement in 
constant-load cycling endurance time following the completion of the training programmes. 
However, patients who exercised twice daily demonstrated significantly greater improvement in 
cycling endurance time compared to those who trained once daily. The four-fold difference in the 
magnitude of improvement in endurance time between the two groups exceeds the clinically 
meaningful difference (i.e., a 33% improvement in endurance time) described for pharmacological 
and non-pharmacological interventions in patients with COPD [22]. In both groups, the 
improvement in the 6MWT exceeded the clinically meaningful margin of 30 m, but the fraction of 
patients exhibiting clinically meaningful improvements in the 6MWT was significantly greater for 
those patients trained twice daily. This finding reinforces the notion that the effects of exercise 
training are strictly related to the amount of training workload applied [34–37]. 
Furthermore, evidence of true physiological training adaptations for both groups is provided 
by the greater increase in the sustained cycling work rate throughout the programme that was 
achieved by the cardiovascular responses and sensations of breathlessness and leg discomfort 
comparable to those who trained once daily (Figure 2). This suggests that during the rehabilitation 
programme exercise fitness levels improved in both groups as work rates increased, while cardiac 
response and symptoms remained relatively unchanged and similar between groups [12]. 
Interestingly, the clinically meaningful improvement in the 6MWT was highly comparable 
between groups. This finding most likely reflects the inability of severe COPD patients to increase 
walking speed, which is known to be compromised in this population [38]. In fact, the post-training 
6MWT of approximately 410 m recorded in both groups reflects an average walking speed of 
approximately 1.1 m/sec, which represents the upper boundaries of walking speed in severe COPD 
patients [38,39]. In addition, it should be emphasized that training adaptations are specific to 
training modality employed [38]; hence, one would expect cycling training adaptations to be better 
reflected during cycling testing than walking testing. This may also explain the finding that the 
addition of a second training session on a daily basis, as compared to only one daily training session, 
did not have significant additive effects on respiratory or peripheral muscle strength. 
Similarly, both training modalities induced comparable improvements in other clinical 
outcomes, namely MRC, CAT, and MRF scores. A lack of significant differences in the magnitude of 
improvement in these outcomes is most likely attributed to the multidisciplinary component of the 
comprehensive pulmonary rehabilitation programme; this one was designed to improve, in addition 
to exercise tolerance, symptoms and quality of life. Hence, doubling the number of sessions during 
inpatient rehabilitation conveys superior effects on exercise tolerance along with clinically 
meaningful improvements in symptoms and quality of life. 
4.1. Clinical Implications 
When compared to international recommendations for pulmonary rehabilitation [2], our 
findings suggest that a higher volume of training could be applied in the setting of a short-term 
inpatient pulmonary rehabilitation program to reach higher levels of exercise tolerance and that it 
meaningfully improved quality of life and reduced sensations of breathlessness. Hence, training 
dosage is important during pulmonary rehabilitation and can have a substantial effect on the 
magnitude of exercise-induced physiological adaptations. While resources available to other 
pulmonary rehabilitation centers globally may limit the applicability of our approach to offer two 
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training sessions per day, our findings are highly pertinent to these National Health Systems that 
provide a short period of inpatient rehabilitation: in this case, patients may be encouraged to attend 
two training sessions per day in an attempt to boost their fitness levels.  
4.2. Limitations  
We acknowledge that our study has a number of limitations. We did not perform a 
Cardiopulmonary Exercise Test (CPET) at the outset of the study to precisely set the training 
intensity during exercise training. Instead, we defined the initial training load via estimation from 
the 6MWT [23]. This procedure could have underestimated or overestimated the initial training load 
with respect to the individual patient exercise capacity [40]. Nevertheless, this procedure reflects the 
“real life” assessment commonly used in the pulmonary rehabilitation settings involved in the 
present study where access to time and recourse demanding CPET is not available. This was a 
pragmatic trial reflecting the resources of the average pulmonary rehabilitation center in Italy where 
sophisticated and costly CPET measurements are not available. Furthermore, the lack of CPET 
measurements has not allowed the undertaking of physiological measurements to better appreciate 
the physiological benefits of the two training interventions. Lastly, the very tight patient exclusion 
criteria implemented in the present investigation produced a large sample of excluded patients, 
thereby limiting the external validity of the rehabilitation trial. However, in the real-life setting, we 
are confident that some of the implemented exclusion criteria could be avoided (i.e. pulmonary 
rehabilitation in the previous six months or stability in chronic heart failure) without an adverse 
impact on safety or efficacy. 
5. Conclusion 
The major finding of this study is that, in severe COPD patients, doubling the volume of 
endurance training (twice daily as opposed to once daily) is feasible and can lead to an additional 
benefit on cycling exercise tolerance following the completion of an inpatient pulmonary 
rehabilitation programme. Future studies may investigate the applicability and benefits of this 
training strategy in the outpatient or community-based pulmonary rehabilitation settings to amplify 
the benefits of exercise interventions.  
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